| Předmět: |
|
| Zdroj: |
Inpharma Weekly; 10/28/2006, Issue 1561, p9-19, 8p |
| Abstrakt: |
The article focuses on therapy-related research. A research in Turkey has revealed that combining fludarabine, cytarabine, idarubicin plus granulocyte colony-stimulating factor is effective for the treatment of refractory acute leukemias. A study has found that adalimumab is effective for patients with active Crohn's disease who did not respond to or tolerate infliximab. A U.S. study has found that capecitabine plus temozolomide is active and well tolerated in the treatment of brain metastases in breast cancer patients. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
